Sorafenib; BAY 43-9006; Sorafenib Base; Sorafenib Free Base

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
500 mg	In-stock	$126.00	Visible after login	- +
1 g	In-stock	$188.00	Visible after login	- +

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

500 mg

In-stock

$126.00

Visible after login

- +

1 g

In-stock

$188.00

Visible after login

- +

Product Overview

Product Name	Sorafenib; BAY 43-9006; Sorafenib Base; Sorafenib Free Base
CAS	284461-73-0
Formula	C21H16ClF3N4O3
MW	464.82
Appearance	White to off-white powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Sorafenib (BAY549085; BAY-549085; BAY439006; BAY-439006; Nexavar; SFN) an approved anticancer medication, is a potent and orally bioavailable multikinase inhibitor with potential anticancer activity (BAY549085; BAY-549085; BAY439006; BAY-439006; Nexavar; SFN). In enzymatic assays, it inhibits numerous kinases, including Raf-1, B-Raf, and VEGFR-2, with IC50 values of 6 nM, 22 nM, and 90 nM, respectively. The FDA granted sorafenib approval in 2005 to treat advanced renal cancer.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL1076

Sorafenib; BAY 43-9006; Sorafenib Base; Sorafenib Free Base

284461-73-0 98+%

Sorafenib; BAY 43-9006; Sorafenib Base; Sorafenib Free Base

Chemical safety data sheet(MSDS)

Certificate Of Authenticity(CPA)